AstraZeneca CEO Praises Unique Support from Chinese Government
AstraZeneca CEO Pascal Soriot praises the unique support from the Chinese government, noting a partnership that boosts public health and economic growth.
AstraZeneca
Read More
AstraZeneca Aims to Launch 100 New Medicines in China 🚀
AstraZeneca plans to launch at least 100 new medicines in China over the next five years, collaborating with Chinese partners to drive innovation.
FDA Approves Self-Administered Nasal Spray Flu Vaccine 💉🎉
Needle-free flu vaccines are here! The FDA approved FluMist for self-use, making it easier to protect yourself and others from the flu starting next fall. 💉
AstraZeneca Bets Big on China’s Innovation Scene with $700M Investment 🚀
AstraZeneca invests $700 million in China’s Qingdao City, signaling the pharma giant’s belief that China is the top spot for innovation. Learn how this move could shake up global biotech! 🚀
AstraZeneca CEO Praises China’s Innovation and Supply Chain at 2024 Boao Forum
AstraZeneca CEO Pascal Soriot shares exciting insights at the 2024 Boao Forum on China’s growth and its leading role in biopharmaceutical innovation and supply chain efficiency.
China Leads the Next Biopharma Revolution, Says AstraZeneca CEO
AstraZeneca CEO Pascal Soriot announces China’s leading role in biopharmaceutical innovation at the Boao Forum 2024, highlighting job growth and groundbreaking advancements.
AstraZeneca Boosts Innovation and Investment in China for Global Health Growth
AstraZeneca CEO Pascal Soriot discusses the company’s big investments in China, transforming it into a global hub for manufacturing and innovation, boosting global health and economic growth.